What is the standard approach to hyperbilirubinemia in term and preterm neonates, including the roles of phototherapy and exchange transfusion?

• A. Phototherapy for significant unconjugated bilirubin elevations; exchange transfusion reserved for severe hyperbilirubinemia or signs of acute bilirubin encephalopathy based on gestational age and hours.
• B. Exchange transfusion is first-line for all elevated bilirubin.
• C. Phototherapy is never used; always perform exchange transfusion.
• D. No treatment is needed.

Answer: (A)

Managing neonatal hyperbilirubinemia starts with phototherapy as the main first-line treatment for significant unconjugated bilirubin elevations in both term and preterm infants. Phototherapy uses blue light to convert bilirubin into water-soluble isomers that can be excreted without needing further liver conjugation, lowering bilirubin levels without invasive procedures. It’s noninvasive and should be combined with careful supportive care—ensuring adequate hydration, monitoring temperature, and protecting the infant’s eyes. Exchange transfusion, on the other hand, is an invasive, higher-risk intervention reserved for situations where bilirubin levels are very high or there are signs of acute bilirubin encephalopathy, and the decision hinges on gestational age and the infant’s age in hours, with thresholds adjusted accordingly. In term and especially preterm babies, these age- and gestational-age–adjusted thresholds guide when to escalate from phototherapy to exchange transfusion to prevent bilirubin-induced neurologic damage. The exchange transfusion rapidly removes bilirubin-containing plasma and replaces it with donor blood, and can also correct concurrent anemia, but its risks mean it’s used only when necessary. So, the standard approach is to treat with phototherapy for significant unconjugated bilirubin elevations, reserving exchange transfusion for severe cases or encephalopathy based on gestational age and time since birth.